טוען...
B7-H1 signaling is integrated during CD8(+) T cell priming and restrains effector differentiation
A promising strategy in tumor immunotherapy is the use of activated dendritic cells as vehicles for tumor vaccines with the goal of activating anti-tumor T cell responses. Current formulations for dendritic cell-based immunotherapies have limited effects on patient survival, providing motivation for...
שמור ב:
| הוצא לאור ב: | Cancer Immunol Immunother |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833388/ https://ncbi.nlm.nih.gov/pubmed/24893858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1563-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|